Guru Ownership Trend
Guru Analysis for Caris Life Sciences, Inc. (CAI)
Caris Life Sciences, Inc. (CAI), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q3 2026, a total of 4 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $164.75 M.
Top institutional holders include Cliff Asness and Renaissance Technologies (RenTech).
Institutional sentiment is currently Strongly Bullish. This is evidenced by a $227.13 M net inflow during the quarter.
Recent activity highlights Cliff Asness who dramatically increased their stake.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q3 2026)
Guru Consensus (Q3 2026)
FAQs for Caris Life Sciences, Inc. (CAI)
Major holders include Cliff Asness ($251.49 M), Renaissance Technologies (RenTech) ($20.11 M), Joel Greenblatt ($10.46 M). According to the latest reported data, 4 tracked investment managers collectively hold approximately 9.37 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $227.13 M, with 4 managers increasing positions and 2 managers reducing holdings.
During the most recent reporting period, 0 managers trimmed their positions, while 2 fully exited CAI. The total reported sell value was $34.9 M.
Yes, 0 managers opened new positions in CAI, and 4 increased their existing holdings. The total reported buy value was $262.03 M.